Insights On Downstream Manufacturing

  1. Fab Antibody Fragment Titer Improvement 2/2/2026

    Learn how systematic screening of unique expression strains and plasmid combinations can overcome low protein yields, achieving active Fab titers over 4 g/L.

  2. The Hidden Challenges Of ADC Manufacturing - And How To Overcome Them 1/30/2026

    ADC manufacturing requires specialized expertise, single‑use systems, precise filtration, aseptic filling, and integrated lyophilization to ensure stability, safety, and consistent clinical‑grade production.

  3. Regulatory Compliance And Advanced Solutions For Aseptic Environmental Monitoring 1/29/2026

    Modern aseptic monitoring requires a shift from periodic checks to risk-based strategies. Learn how to integrate particle and environmental data to meet Annex 1 standards and ensure patient safety.

  4. How Do You Protect Incubation Workflows From Contamination And Downtime? 1/29/2026

    Active HEPA filtration protects cell cultures by restoring air quality within minutes. Learn how continuous purification reduces contamination risks and ensures reliable, reproducible research.

  5. MPLC System: Efficient Purification for Mid-Sized Therapeutics 1/28/2026

    Discover how to enhance purification for mid-sized therapeutics with advanced pressure capabilities. Learn to balance automation and regulatory compliance for more reliable, precise batches.

  6. A Trusted New Partnership 1/28/2026

    Optima delivers high‑quality, flexible syringe and vial filling solutions with fast qualification, U.S.‑based support, and long‑term partnership reliability, helping CDMOs scale efficiently and confidently.

  7. Handling Demanding Active Ingredients Safely And Efficiently 1/27/2026

    See three flexible Optima fill‑finish and syringe assembly systems to boost performance, accuracy, and scalability, enabling efficient processing of diverse formats and supporting rapid CDMO growth.

  8. Choosing The Right Sample For HCP Antibody Coverage Analysis 1/27/2026

    Selecting the right sample is vital for accurate HCP antibody coverage. Learn how to navigate the limitations of traditional methods and ensure your ELISA is truly fit-for-purpose.

  9. Implications For Drug Product Efficacy, Quality And Safety 1/27/2026

    Move beyond general detection toward targeted risk assessment. Identify problematic impurities that impact drug stability and learn to standardize your analytical control strategies.

  10. Best Practices For When To Leverage Mass Spectrometry For HCP Analytics 1/27/2026

    Go beyond the ELISA by leveraging mass spectrometry. Identify specific high-risk proteins and ensure your purification process meets the highest standards of safety.